Form D · Venture Capital Fund
Israel Biotech Fund I, L.P.
Tel Aviv, L3 · CIK 0001652458
Offering snapshot reported Oct 22, 2015 · SEC filing
- Reported sold
- Yet to sell Offering amount: $100M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 22, 2015 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.7
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-249881
Source: Form D, filed Oct 22, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
The linked fund shows its most recently reported ADV details.
Matched by reported Form D file number
ISRAEL BIOTECH FUND I, L.P.
Investment adviser: I.B.F. MANAGEMENT LTD.
- Gross asset value
- $25M
- Beneficial owners
- 61
- ADV minimum commitment
- $25K
Reported in Form ADV on Feb 4, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.
Service providers
Provider details
- Annual audit
- Yes
- Prime brokers
- No
- Custodians
- No
- Administrator other than the adviser
- No
- External marketing
- No
KESSELMAN & KESSELMAN, A MEMBER FIRM OF PRICEWATERHOUSECOOPERS INTERNATIONAL LIMITED
PCAOB 1309
Filing source
Form ADV 2048892 · Feb 4, 2026 · Schedule D 7.B.(1), fund 805-3791898329
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Yuval Cabilly | Executive |
| David Sidransky | Executive |
| Ido Zairi | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:Tel Aviv, L3, 6937215